We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-18.28%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$108M
AUM Growth
-$29.3M
Cap. Flow
+$2.28K
Cap. Flow %
0%
Top 10 Hldgs %
11.75%
Holding
231
New
44
Increased
72
Reduced
109
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 31.59%
2 Healthcare 25.12%
3 Consumer Discretionary 11.8%
4 Industrials 8.13%
5 Communication Services 7.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARVN icon
151
Arvinas
ARVN
$530M
$309K 0.29%
+7,334
New +$368K
DHR icon
152
Danaher
DHR
$138B
$308K 0.28%
1,368
-1,558
-53% -$359K
CSTL icon
153
Castle Biosciences
CSTL
$742M
$307K 0.28%
13,970
-3,561
-20% -$82.7K
VIR icon
154
Vir Biotechnology
VIR
$1.46B
$307K 0.28%
12,066
-3,332
-22% -$77.8K
BPMC
155
DELISTED
Blueprint Medicines
BPMC
$303K 0.28%
6,005
-2,406
-29% -$141K
PANW icon
156
Palo Alto Networks
PANW
$256B
$303K 0.28%
3,684
-594
-14% -$52.7K
BLK icon
157
Blackrock
BLK
$167B
$301K 0.28%
494
-421
-46% -$274K
REGN icon
158
Regeneron Pharmaceuticals
REGN
$72.9B
$299K 0.28%
505
-746
-60% -$485K
RILY icon
159
BRC Group Holdings
RILY
$264M
$299K 0.28%
7,080
+992
+16% +$52.1K
LAW icon
160
CS Disco
LAW
$271M
$297K 0.27%
+16,487
New +$425K
MC icon
161
Moelis & Co
MC
$4.85B
$296K 0.27%
7,524
-1,367
-15% -$59.6K
TDOC icon
162
Teladoc Health
TDOC
$1.66B
$295K 0.27%
8,877
-2,703
-23% -$115K
UTHR icon
163
United Therapeutics
UTHR
$26.1B
$293K 0.27%
1,242
-1,055
-46% -$214K
LAND
164
Gladstone Land Corp
LAND
$365M
$292K 0.27%
13,163
-12,655
-49% -$382K
PNFP icon
165
Pinnacle Financial Partners Inc
PNFP
$15.8B
$286K 0.26%
3,950
-1,889
-32% -$149K
DDOG icon
166
Datadog
DDOG
$94B
$283K 0.26%
2,968
+1,628
+121% +$179K
AR icon
167
Antero Resources
AR
$10.9B
$281K 0.26%
9,184
-44
-0.5% -$1.61K
KRYS icon
168
Krystal Biotech
KRYS
$10.7B
$281K 0.26%
+4,278
New +$266K
CUBI icon
169
Customers Bancorp
CUBI
$2.66B
$277K 0.26%
8,174
-494
-6% -$20.1K
ROKU icon
170
Roku
ROKU
$21.6B
$275K 0.25%
3,351
-129
-4% -$12.5K
WAL icon
171
Western Alliance Bancorporation
WAL
$8.81B
$274K 0.25%
3,887
+374
+11% +$28.6K
BBIO icon
172
BridgeBio Pharma
BBIO
$16.4B
$272K 0.25%
+30,009
New +$251K
GRWG icon
173
GrowGeneration
GRWG
$84.7M
$272K 0.25%
75,783
-6,822
-8% -$38.9K
RH icon
174
RH
RH
$3.33B
$272K 0.25%
1,281
+614
+92% +$182K
ARES icon
175
Ares Management
ARES
$28.1B
$255K 0.24%
4,478
+309
+7% +$21.4K

Similar funds

Capital Impact Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Capital Impact Advisors held 231 positions worth $108M, down 21% from $138M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors's Q2 2022 filing shows 44 new, 72 increased, 109 reduced and 5 closed positions. Its largest new stake was Domo: 19,872 shares worth $552K. The largest sale was Advance Auto Parts, an estimated $1.11M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Impact Advisors's largest Q2 2022 buy was Domo: 19,872 shares worth $552K.
  • Capital Impact Advisors added most to Amazon in Q2 2022, an estimated $858K increase.
  • Capital Impact Advisors's biggest Q2 2022 reduction was Advance Auto Parts, cutting an estimated $1.11M.
  • Capital Impact Advisors fully exited Service Corp International in Q2 2022, selling an estimated $1.03M.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $108M portfolio in Q2 2022.
  • Capital Impact Advisors opened 44 new positions and closed 5 in Q2 2022.
  • Capital Impact Advisors's portfolio value fell 21% quarter-over-quarter to $108M.

Based on Capital Impact Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.